Effects of the vasopeptidase inhibitor omapatrilat on cardiac endogenous kinins in rats with acute myocardial infarction
- 30 May 2001
- Vol. 22 (6), 953-962
- https://doi.org/10.1016/s0196-9781(01)00401-6
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Type 2 Bradykinin-Receptor Antagonism Does Not Modify Kinin or Angiotensin Peptide LevelsHypertension, 1999
- Des-Arg9-bradykinin metabolism in patients who presented hypersensitivity reactions during hemodialysis: role of serum ACE and aminopeptidase PPeptides, 1999
- Absence of effect of chronic angiotensin II type 1 receptor blockade on endogenous kinin concentrations in the carrageenan-induced paw edema model in the ratPeptides, 1999
- Angiotensin-Converting Enzyme InhibitorsCirculation, 1998
- Contribution of angiotensin-converting enzyme to the cardiac metabolism of bradykinin: an interspecies studyAmerican Journal of Physiology-Heart and Circulatory Physiology, 1997
- Involvement of endogenous kinins in the pathogenesis of peptidoglycan-induced arthritis in the Lewis ratArthritis & Rheumatism, 1997
- Diagnostic efficiency of Troponin T measurements in rats with experimental myocardial cell damageExperimental and Toxicologic Pathology, 1995
- Development of digoxigenin-labeled peptide: Application to chemiluminoenzyme immunoassay of bradykinin in inflamed tissuesPeptides, 1994
- Ramiprilat increases bradykinin outflow from isolated hearts of ratBritish Journal of Pharmacology, 1993
- Candoxatril, a neutral endopeptidase inhibitorJournal Of Hypertension, 1992